本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1997/8/151 分钟阅读
New Drug Applications and Abbreviated New Drug Applications; Editorial Amendments
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending its new drug application (NDA) and abbreviated new drug application (ANDA) regulations to reflect a reorganization in the Center for Drug Evaluation and Research (CDER). This action will improve the accuracy of the regulations.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →